4553 JPX Week ended 07 Aug 2026

Weekly Investor Report

Towa Pharmaceutical Co., Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 3,950 JPY
-1.4% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -0.1% below the Trend Line and sits at 69.2% of its 52-week range. The latest completed week returned -1.4%, after a -1.9% four-week move. The latest news-sentiment score is 50/100.

Setup score 52 out of 100
Latest Close 3,950 JPY 7 Aug 2026
1W Return -1.4% latest completed week
4W Return -1.9% short-term follow-through
12W Return 4.5% quarterly tape
Trend Breadth 78.8% 41 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
  • Next-week expectancy is positive at 60.10% based on similar historical setup states.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.4% Latest completed week; four-week move -1.9%. Indicator stack 43/58 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 60.10% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 4 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -0.1% below the Trend Line and sits at 69.2% of its 52-week range. The latest completed week returned -1.4%, after a -1.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5412-week average 0.62

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.54Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.9% over four weeks, 4.5% over 12 weeks, and 37.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-1.4%
4W-1.9%
12W4.5%
26W9.7%
52W37.2%
Active trend streak0 weeks
Active weeks in one year41
Trend breadth78.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change100.4%Four-week change in activity pressure.
Leadership-7.92Latest relative-leadership reading.
RS change31.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 4 relevant articles.

0 positive · 4 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-12.0%Distance below the 52-week high.
13-week volatility3.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+15.9%Week of 20 Feb.
Worst week-7.3%Week of 5 Jun.
Latest week-1.4%Week of 7 Aug.

Shape of recent returns

Strong gains4
Modest gains10
Flat weeks0
Modest losses9
Sharp losses3
Recent vol3.3%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew3.1% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape52/100

Trend, activity pressure, participation, and risk combine to a 52/100 tape read.

 Indicator analysis27/100

Latest 12-week confirmation: trend 5/12, activity pressure 1/12, relative leadership 0/12.

Activity pressure 0.54; 2 reversal markers Next-Week ExpectancyPositive 60.10%

Next-week expectancy is positive with a 60.10% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 4 relevant articles.

Towa Pharmaceutical (TSE:4553) Stock Faces Margin Questions After Profit Rebound Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20263,950 JPY-1.4%3,955 JPY3,010 JPY0.00-7.92577.4KOff
31 Jul 20264,005 JPY-2.7%3,942 JPY2,996 JPY-0.07-5.07617.4KOn
24 Jul 20264,115 JPY-1.8%3,929 JPY2,981 JPY-0.32-3.36439.8KOn
17 Jul 20264,190 JPY4.1%3,914 JPY2,965 JPY-0.59-1.23590.5KOff
10 Jul 20264,025 JPY2.5%3,896 JPY2,949 JPY-0.90-11.58788.3KOff
3 Jul 20263,925 JPY4.7%3,877 JPY2,933 JPY-1.14-15.65104.6KOff
26 Jun 20263,750 JPY1.6%3,856 JPY2,919 JPY-1.22-19.33150.1KOff
19 Jun 20263,690 JPY-1.7%3,839 JPY2,905 JPY-1.16-23.14181.5KOff
12 Jun 20263,755 JPY2.6%3,819 JPY2,893 JPY-1.06-16.15147.2KOff
5 Jun 20263,660 JPY-7.3%3,792 JPY2,879 JPY-0.90-19.41142.6KOn
29 May 20263,950 JPY1.5%3,762 JPY2,866 JPY-0.82-13.32582.0KOn
22 May 20263,890 JPY2.9%3,724 JPY2,852 JPY-0.76-11.09744.3KOn
15 May 20263,780 JPY-3.3%3,690 JPY2,838 JPY-0.57-11.311.9MOn
8 May 20263,910 JPY-1.3%3,658 JPY2,825 JPY-0.30-10.46217.6KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context